118 related articles for article (PubMed ID: 1359571)
1. Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: comparison with typical and atypical antipsychotics.
Britton DR; Curzon P; Yahiro L; Buckley M; Tufano M; Nadzan A
Pharmacol Biochem Behav; 1992 Oct; 43(2):369-76. PubMed ID: 1359571
[TBL] [Abstract][Full Text] [Related]
2. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
Blackburn JR; Phillips AG
Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431
[TBL] [Abstract][Full Text] [Related]
3. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802.
White IM; Ciancone MT; Haracz JL; Rebec GV
Pharmacol Biochem Behav; 1992 Jan; 41(1):29-35. PubMed ID: 1347175
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
Hu XT; Wang RY
Brain Res; 1989 May; 486(2):325-33. PubMed ID: 2786442
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
[TBL] [Abstract][Full Text] [Related]
6. WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.
Grauer SM; Graf R; Navarra R; Sung A; Logue SF; Stack G; Huselton C; Liu Z; Comery TA; Marquis KL; Rosenzweig-Lipson S
Psychopharmacology (Berl); 2009 May; 204(1):37-48. PubMed ID: 19107466
[TBL] [Abstract][Full Text] [Related]
7. The effects of clozapine on shuttle-box avoidance responding in rats: comparisons with haloperidol and chlordiazepoxide.
Sanger DJ
Pharmacol Biochem Behav; 1985 Aug; 23(2):231-6. PubMed ID: 4059310
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats.
Parikh V; Khan MM; Terry A; Mahadik SP
J Psychiatr Res; 2004; 38(5):521-9. PubMed ID: 15380403
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
Hand TH; Hu XT; Wang RY
Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
[TBL] [Abstract][Full Text] [Related]
10. A rapidly acquired one-way conditioned avoidance procedure in rats as a primary screening test for antipsychotics: influence of shock intensity on avoidance performance.
van der Heyden JA; Bradford LD
Behav Brain Res; 1988 Nov; 31(1):61-7. PubMed ID: 2906543
[TBL] [Abstract][Full Text] [Related]
11. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
Costall B; Naylor RJ
Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562) in rats.
Takamori K; Funakoshi T; Hirota S; Chaki S; Kameo K
Life Sci; 2002 Jul; 71(8):947-52. PubMed ID: 12084391
[TBL] [Abstract][Full Text] [Related]
13. The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.
Holly EN; Ebrecht B; Prus AJ
Eur Neuropsychopharmacol; 2011 Jul; 21(7):526-31. PubMed ID: 21277173
[TBL] [Abstract][Full Text] [Related]
14. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance.
Murphy CA; Feldon J
Behav Pharmacol; 2000 Jun; 11(3-4):307-16. PubMed ID: 11103885
[TBL] [Abstract][Full Text] [Related]
15. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
Pillai A; Parikh V; Terry AV; Mahadik SP
J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057
[TBL] [Abstract][Full Text] [Related]
16. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
[TBL] [Abstract][Full Text] [Related]
17. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
Cohen SL; Knight M; Tamminga CA; Chase TN
Eur J Pharmacol; 1982 Sep; 83(3-4):213-22. PubMed ID: 6129145
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of dopamine and AMPA receptor antagonists on the expression of conditioned avoidance responding in rats.
Boivin GA; Beninger RJ
Behav Neurosci; 2008 Apr; 122(2):377-84. PubMed ID: 18410176
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.
Russig H; Kovacevic A; Murphy CA; Feldon J
Psychopharmacology (Berl); 2003 Nov; 170(3):263-270. PubMed ID: 12898122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
